About   Help   FAQ
Cdkn2atm1(cre/ERT2)Mkt - Cardiovascular System
Recombinase Activity Detail
Allele Information
Allele:
Cdkn2atm1(cre/ERT2)Mkt
cyclin dependent kinase inhibitor 2A; targeted mutation 1, Makoto Nakanishi
Driver: Cdkn2a
Type: Targeted (Inducible, Recombinase)
Inducer: tamoxifen
Synonym: p16-CreERT2, p16Ink4a-CreERT2neo
Molecular description: The exon 1 alpha of the Cdkn2a gene was replaced with a translation start site, a CreERT2 expression cassette and a neo cassette. The retained neo-resistant gene markedly resulted in higher labeling efficacy at this locus presumably due to the fact that a retained neo-resistant cassette can act as a local enhancer to augment reporter expression without compromising tissue reporter fidelity.
Find mice (IMSR): Mouse Strains: 0 strains available       Cell Lines: 0 lines available
Additional Tissues: Cdkn2atm1(cre/ERT2)Mkt activity also observed in:
Tissue Information
Cardiovascular System Other recombinase alleles with activity in Cardiovascular System tissues:
Recombinase Activity
Click heading to re-sort table.
Assays Genotypic Background Result Notes  
References
All for this allele: 1 reference(s)

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory